Drugs / Autologous platelet-rich plasma (PRP) eye drops
Autologous platelet-rich plasma (PRP) eye drops
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT05515731 | Jan → Dec 2021 | corneal ulcer | Alaa Gamal | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Autologous platelet-rich plasma (PRP) eye drops | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05515731 ↗ |
| Modality | Other / unclassified | “Autologous platelet-rich plasma eye drops are derived from treatment of patients plasma using special process.” NCT05515731 ↗ |
| Route | Topical | “All patients were treated with E-PRP drops (one drop)” NCT05515731 ↗ |